Tryp Therapeutics Inc.

Upcoming Events

Jul 7 - Jul 7, 2021

TRYP THERAPEUTICS TO SPEAK & PRESENT AT THE PSYCHED INVESTOR SUMMIT

Jul 13 - Jul 14, 2021

TRYP THERAPEUTICS TO PRESENT AT THE LADENBURG THALMANN 2021 HEALTHCARE CONFERENCE

San Diego, California--(Newsfile Corp. - June 8, 2021) -  Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (FSE: 8FW) ("Tryp"), a pharmaceutical company focused on developing compounds for diseases with unmet medical needs through accelerated regulatory pathways, announced today that it is presenting at the Ladenburg Thalmann Healthcare Conference. The conference will be held virtually on July 13 and 14. Greg McKee, Chairman and CEO; Jim Gilligan, President and Chief Science Officer; and Luke Hayes, CFO, will provide an overview of Tryp's business and its pipeline followed by a brief analyst-led fireside chat.

Details of the presentation are as follows:

Date: Tuesday, July 13, 2021
Time: 3:00 - 3:25 p.m. EDT
Location: Virtual
Registration: Ladenburg Thalmann 2021 Healthcare Conference

Aug 10 - Aug 12, 2021

TRYP THERAPEUTICS TO PRESENT AT THE CANACCORD ANNUAL GROWTH CONFERENCE


Past Events

Jun 22 - Jun 23, 2021

TRYP THERAPEUTICS TO PRESENT AT THE PSYCHEDELIC OPPORTUNITY SUMMIT

Jun 17 - Jun 17, 2021

TRYP THERAPEUTICS TO PRESENT AT THE H.C. WAINWRIGHT PSYCHEDELICS CONFERENCE

Details of the presentation are as follows:

 

Date:                Thursday, June 17th, 2021

Time:                Tryp’s presentation will be available to access beginning at 7:00 a.m. EDT

Registration:   https://hcwevents.com/psychedelics/

Feb 3 - Feb 4, 2021

Canaccord Psychedelic Investment Conference

Jan 26 - Jan 28, 2021

EDISON Global Healthcare Conference

Tryp Therapeutics, a leading pharmaceutical company focused on identifying and developing clinical-stage compounds for diseases with high unmet medical needs, has been invited to present at the EDISON Global Heathcare Conference. 

Please sign up to receive updates